Medpace Hldgs Q1 2024 GAAP EPS $3.20 Beats $2.46 Estimate, Sales $511.000M Miss $512.585M Estimate
Portfolio Pulse from Benzinga Newsdesk
Medpace Holdings (MEDP) reported Q1 2024 earnings of $3.20 per share, surpassing the $2.46 estimate, but its sales of $511M fell short of the $512.585M forecast. This represents a 17.72% increase in sales compared to the same period last year.
April 22, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medpace Holdings reported higher-than-expected Q1 2024 earnings per share but slightly missed sales estimates. Year-over-year sales increased by 17.72%.
The significant beat on earnings per share (EPS) is likely to positively impact investor sentiment and Medpace's stock price in the short term, despite the slight miss on sales estimates. The substantial year-over-year sales growth further underscores the company's strong performance and may mitigate concerns about the sales miss.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100